<DOC>
	<DOC>NCT00308295</DOC>
	<brief_summary>The main goal of this study is to determine whether the American Heart Association-recommended fish oil dose is efficacious, safe, and tolerable in hemodialysis patients. The secondary objective is to test the effects of fish oil supplementation on inflammatory and cardiovascular markers.</brief_summary>
	<brief_title>A Pilot Study of Fish Oil Supplementation in Hemodialysis Patients</brief_title>
	<detailed_description />
	<mesh_term>Kidney Failure, Chronic</mesh_term>
	<criteria>1. Age &lt;18 2. Pregnant individuals 3. Fish oil or omega3 supplementation in past 6 months 4. Fish, corn, soybean, gelatin, or vanilla allergies 5. Currently enrolled in a dietary or investigational drug study 6. Life expectancy &lt; 3 months 7. Ongoing active illness requiring hospitalization 8. Malabsorption syndromes 9. Chronic heparin or coumadin anticoagulation (??) 10. Active bleeding issues</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>82 Years</maximum_age>
	<verification_date>October 2007</verification_date>
</DOC>